Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Zovaglutide - QL Biopharmaceutical

Next Previous
Drug Profile

Zovaglutide - QL Biopharmaceutical

Alternative Names: ZT-002

Latest Information Update: 06 Mar 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator QL Biopharmaceutical
  • Class Antidementias; Antihyperglycaemics; Hepatoprotectants; Obesity therapies
  • Mechanism of Action Glucagon-like peptide-1 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase III Obesity
  • Phase I/II Type 2 diabetes mellitus
  • Phase I Alzheimer's disease; Non-alcoholic steatohepatitis

Most Recent Events

  • 02 Mar 2026 QL Biopharmaceutical plans a phase I trial for Obesity in China (SC, Injection) in April 2026 (NCT07443059)
  • 28 Oct 2025 No recent reports of development identified for phase-I development in Type-2-diabetes-mellitus in Australia (SC, Controlled release)
  • 18 Sep 2025 Phase-III clinical trials in Obesity (SC)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top